Postpartum bipolar disorder appears to have a somewhat distinct clinical profile in terms of timing and symptom pattern, but current evidence suggests it is better conceptualized as a subtype of bipolar disorder rather than a fully separate diagnostic entity.
Establishing noninvasive and low-cost data collection based on childbirth narratives for the identification of women with CB-PTSD could serve as an important first step to complement more extensive methods.
Vigilance is required in screening women who present with postpartum depression; a subset of women who screen positive for depression may actually have bipolar disorder.
There is evidence that screening for perinatal mood and anxiety disorders may improve outcomes; however, success depends on adequate resources for screening, diagnosis, treatment and follow-up.
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the new recommendation by the Canadian Task Force on Preventative Health Care which advises against systematic questionnaires for PPD screening with Ob.Gyn News on January 20, 2023.
Announcing a new CWMH study on postpartum depression screening and treatment outcomes at Mass General Brigham.
This task force does not recommend universal, instrument-based screening for perinatal depression because we lack clear evidence that screening improves outcomes.
Many women experience depression during pregnancy. What is the best way to identify these women?
About 60% of women with mood disorders experience premenstrual exacerbation or PME of their mood during the premenstrual phase of their cycle.
In a recent article, Margaret Spinelli, MD describes a proposal to the DSM-V committee of the American Psychiatric Association in 2020 arguing for the inclusion of postpartum psychosis as a unique diagnosis...
